Home » Newsletters » BioWorld Science

BioWorld Science

June 4, 2014

View Archived Issues

Early clinical results presented for lentiviral-based anti-HIV therapeutic vaccine

New association of an Alzheimer's-associated polymorphism with major depressive disorder

Pharmacological profile of bifunctional MABAs presented at ATS meeting

New data on lead tetracycline antibiotic presented by Tetraphase

Teriparatide evidences potential for spinal fusion and fractures

Roche patent divulges novel K(Ca)3.1 channel blockers

Cephalon researchers prepare and test bendamustine prodrugs

Ohio State University reports development of gemcitabine analogues

Preliminary findings reported for anti-CD37 ADC in patients with NHL

MSD plans phase III trial of MK-8228 to prevent CMV infection in HSCT recipients

Trevi plans phase II studies of nalbuphine ER in uremic pruritus

Asterias Biotherapeutics receives grant for trial of stem cell therapy in spinal cord injury

Innate Pharma and Enzo Biochem validate ProteoStat for ADC stability testing

QIAGEN and Lilly collaborate on DNA and RNA diagnostic for cancer

Spanish researchers prepare new prolyl endopeptidase inhibitors

Agios Pharmaceuticals discloses new PKLR and/or PKM activators

Novel PI3Kdelta inhibitor demonstrates clinical efficacy for hematologic malignancies

Adaptimmune and GSK establish cancer immunotherapy collaboration

MediWound expands distribution of NexoBrid to South Korea

Sequenom bioscience business acquired by Agena Bioscience

Award to support trial of Sangamo's ZFP therapeutic for HIV/AIDS

The FDA grants orphan drug status to PF-02545920 for Huntington's disease

Health Canada accepts Ravicti NDS for priority review

EMA accepts Hetlioz MAA for review

ChemoCentryx's CCX-168 receives U.S. orphan drug status for ANCA-associated vasculitis

Invega approved in E.U. for schizophrenia in adolescents

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...